共 18 条
[1]
Watanabe K(2022)Tumor-informed approach improved ctDNA detection rate in resected pancreatic cancer Int J Mol Sci. 23 11521-1870
[2]
Nakamura T(2023)Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging Mol Oncol. 17 1857-3521
[3]
Kimura Y(2023)Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan J Clin Oncol. 41 3521-134
[4]
Edland KH(2023)Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer Nat Med. 29 127-10207
[5]
Tjensvoll K(2017)Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers Proc Natl Acad Sci USA 114 10202-824
[6]
Oltedal S(2023)Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection J Hepatobiliary Pancreat Sci. 30 815-undefined
[7]
Oki E(undefined)undefined undefined undefined undefined-undefined
[8]
Kotani D(undefined)undefined undefined undefined undefined-undefined
[9]
Nakamura Y(undefined)undefined undefined undefined undefined-undefined
[10]
Kotani D(undefined)undefined undefined undefined undefined-undefined